primary immune deficiency
Showing 1 - 21 of 21
Adult Patients With Immunodeficiency Within the Scope of the ICF
Recruiting
- Primary Immune Deficiency
- +3 more
-
Ankara, Hacettepe Unıversity, TurkeyEbru Çalık Kutukcu
Aug 23, 2023
Bronchiectasis, Cystic Fibrosis, Primary Ciliary Dyskinesia Trial in Haifa (spirometry, Salbutamol, )
Recruiting
- Bronchiectasis
- +4 more
- spirometry
- +2 more
-
Haifa, IsraelRambam Health Campus
Jun 30, 2023
Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell
Recruiting
- Primary Immune Deficiency
-
Bethesda, Maryland
- +6 more
Feb 2, 2023
Primary Immune Deficiency Trial (Asceniv™)
Recruiting
- Primary Immune Deficiency
- Asceniv™
-
Centennial, Colorado
- +2 more
Sep 13, 2022
Primary Immune Deficiency Trial in Suresnes (MRI procedure)
Recruiting
- Primary Immune Deficiency
- MRI procedure
-
Suresnes, FranceFoch hospital
Jul 25, 2022
Primary Immune Deficiency Trial in Worldwide (Newnorm)
Recruiting
- Primary Immune Deficiency
- Newnorm
-
Irvine, California
- +16 more
Jul 1, 2022
Immunological Disease, Autoimmune Diseases, Primary Immune Deficiency Trial in New York
Recruiting
- Immunological Disease
- +2 more
-
New York, New YorkMount Sinai
Apr 13, 2022
COVID-19 Vaccine Responses in PIDD Subjects
Recruiting
- X-linked Agammaglobulinemia
- +6 more
-
Saint Petersburg, Florida
- +2 more
Apr 7, 2022
Suppurative Lung Disease in Children and Adults
Recruiting
- Primary Ciliary Dyskinesia
- +2 more
- Genetic Testing for PCD or PID
- Unaffected Family Member Genetic Testing
-
Palo Alto, California
- +7 more
Mar 30, 2022
Upper Airway Manifestations in Primary Ciliary Dyskinesia and
Recruiting
- Primary Ciliary Dyskinesia
- +2 more
-
Saint Louis, Missouri
- +3 more
Mar 30, 2022
Primary Immune Deficiency Trial run by the NIAID (Pneumovax, Rabavert, Prevnar)
Terminated
- Primary Immune Deficiency
- Pneumovax
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 14, 2021
Primary Immune Deficiency, COVID Trial in Paris
Recruiting
- Primary Immune Deficiency
- COVID
-
Paris, FranceImagine Institute
Sep 1, 2021
Lymphoma, Leukemia, Myeloma Trial in London (CD62L- Tem)
Recruiting
- Lymphoma
- +6 more
- CD62L- Tem
-
London, United KingdomUCLH
Oct 22, 2019
Primary Immune Deficiency, Secondary Immune Deficiency Trial in Montreal (Subcutaneous Immune Globulin (Human) (Hizentra))
Completed
- Primary Immune Deficiency
- Secondary Immune Deficiency
- Subcutaneous Immune Globulin (Human) (Hizentra)
-
Montreal, Canada
- +1 more
Feb 23, 2018
Health Status and Quality of Life in Primary Immunodeficiencies
Unknown status
- Primary Immune Deficiency
-
Marseille, FranceAssistance Publique Hôpitaux de Marseille
Aug 11, 2016
Primary Immune Deficiency Trial in Japan (Immune Globulin Subcutaneous (Human) (SCIG))
Completed
- Primary Immune Deficiency
- Immune Globulin Subcutaneous (Human) (SCIG)
-
Nagoya city, Aichi Pref., Japan
- +9 more
Nov 25, 2014
Primary Immune Deficiency Trial in Japan (Immune globulin subcutaneous (Human))
Completed
- Primary Immune Deficiency
- Immune globulin subcutaneous (Human)
-
Nagoya city, Aichi Pref., Japan
- +8 more
Nov 25, 2014
Primary Immune Deficiency Trial in Australia, New Zealand (Immunoglobulin G (Ig NextGen 16%))
Completed
- Primary Immune Deficiency
- Immunoglobulin G (Ig NextGen 16%)
-
Campbelltown, New South Wales, Australia
- +8 more
Jun 18, 2013
Primary Immune Deficiency Trial in United States (Human Normal Immunoglobulin for Subcutaneous Administration)
Completed
- Primary Immune Deficiency
- Human Normal Immunoglobulin for Subcutaneous Administration
-
Los Angeles, California
- +12 more
Dec 16, 2012
Retrospective Chart Review of Subcutaneous IgG Use in Infants
Completed
- Primary Immune Deficiency
- Subcutaneous IgG (SCIG)
-
Los Angeles, California
- +4 more
Feb 10, 2011